跳至主要内容
临床试验/NCT07013981
NCT07013981已完成不适用

The Synchronized Trial on Expectant Mothers With Depressive Symptoms by Omega-3 PUFAs (SYNCHRO)in Tokyo: Open Trial

National Science and Technology Council, Taiwan1 个研究点 分布在 1 个国家目标入组 5 人开始时间: 2013年1月9日最近更新:

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
5
试验地点
1
主要终点
Total score of the Hamilton Rating Scale for Depression(HAMD)

研究概览

简要总结

The present study aims to examine the efficacy and safety of omega-3 polyunsaturated fatty acids for pregnant women with depressive symptoms.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Triple (Participant, Care Provider, Outcomes Assessor)

入排标准

年龄范围
20 Years 至 50 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • pregnant women aged 20 years or older.
  • between 12-24 weeks gestation.
  • a Japanese conversational ability to understand the scope of the present trial.
  • planned to return to the hospital for checkup at 4-6 weeks after childbirth.
  • an Edinburgh Postnatal Depression Scale (EPDS) score is 9 or more.
  • to have good physical health judged by obstetricians.

排除标准

  • history and current suspicion of psychosis or bipolar I disorder or substance-related disorder or eating disorder or personality disorder.
  • the item of EPDS concerning suicide ideation is 2 or more.
  • other serious psychiatric symptoms such as self-harm behavior or in need of rapid psychiatric treatment.
  • difficult to expect a normal birth (ex: fetal malformation etc.).
  • having a history of bleeding disorder such as von Willebrand's Disease.
  • regular treatment with aspirin or warfarin within the last 3 months.
  • a smoking habit of ≥40 cigarettes per day.
  • regular treatment with ethyl icosapentate or regular consumption of omega- 3 PUFA supplements within the last 3 months.
  • a habit of eating fish ≥4 times per week.

结局指标

主要结局

Total score of the Hamilton Rating Scale for Depression(HAMD)

时间窗: Twelve weeks

The Hamilton Rating Scale for Depression (HAMD) is a commonly used clinical tool for assessing the severity of depression. The most frequently used version, the HAMD-17, includes 17 items and has a total score range from 0 to 52. Higher scores indicate more severe depressive symptoms and thus a worse outcome, while lower scores suggest milder symptoms or improvement.

次要结局

  • Total scores on the Edinburgh Postnatal Depression Scale(EPDS)(Twelve weeks, 4-6 weeks after childbirth)
  • Brain-derived neurotrophic factor(BDNF)in serum(Twelve weeks, 4-6 weeks after childbirth)
  • Total score of the Hamilton Rating Scale for Depression(HAMD)(4-6 weeks after childbirth)
  • Total score of the Beck Depression Inventory II (BDI-II)(Twelve weeks, 4-6 weeks after childbirth)
  • Major depressive disorder(MDD)as determined by the depression module of the Mini International Neuropsychiatric Interview (MINI)(Twelve weeks, 4-6 weeks after childbirth)
  • Omega-3 fatty acids concentrations in erythrocytes(Twelve weeks, 4-6 weeks after childbirth)
  • Estrogen in serum(Twelve weeks, 4-6 weeks after childbirth)
  • Oxytocin in serum(Twelve weeks, 4-6 weeks after childbirth)
  • Progesterone in serum(Twelve weeks, 4-6 weeks after childbirth)
  • Human chorionic gonadotropin (hCG)in serum(Twelve weeks, 4-6 weeks after childbirth)
  • Phospholipase A2 in plasma(twelve weeks, 4-6 weeks after childbirth)

研究者

发起方
National Science and Technology Council, Taiwan
申办方类型
Other Gov
责任方
Principal Investigator
主要研究者

Kuan-Pin

Professor

National Science and Technology Council, Taiwan

研究点 (1)

Loading locations...

相似试验